QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-secures-major-deal-to-supply-dialysis-products-for-at-home-and-acute-care

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes,...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-announced-a-distribution-agreement-with-nipro-medical-to-supply-liquid-and-dry-acid-and-bicarbonate-hemodialysis-concentrates-as-well-as-its-dry-acid-concentrates-mixer-for-which-nipro-has-the-right-to-distribute-rockwells-products-globally-excluding-us

The agreement will remain in effect for two years with the option to extend the agreement for an additional one-year period and...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-projects-net-sales-to-grow-in-the-mid-to-high-single-digits-in-2025-and-beyond-and-gross-margin-in-2025-to-be-approximately-20-and-reaching-above-25-in-2026-and-beyond

GUIDANCERockwell Medical updates its 2024 guidance as follows: Updated 2024 Guidance (As of August 8, 2024)Updated 2024 Guidanc...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-q1-adj-002-beats-004-estimate-sales-2268m-beat-2170m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0....

 rockwell-medical-enters-new-and-expanded-distribution-agreement-with-bionuclear-and-atlantic-medical-international

In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company. The am...

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-9

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION